NRx has received a positive review letter (Discipline Review Letter) addressing Drug Quality requesting only 'Minor” ...
Picard Medical, Inc. (NYSE American: PMI) ("Picard Medical” or the "Company”), parent company of SynCardia Systems, LLC, ("SynCardia”) maker of the world’s first total artificial heart approved by ...
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
Sixth paragraph, fifth sentence of release issued April 20, 2026 at 10 p.m. PT/April 21, 2026 at 1 a.m. ET, should read: In addition, treatment with Gazyva plus standard therapy, versus placebo plus ...
Ametefgene parvec (AB-1005) manufactured at Viralgen commercial manufacturing facility with next-generation process to deliver high-purity product with greater efficiency AskBio Inc. (AskBio), a ...
Shionogi Inc. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the ...
Ric Powers Christine Powers Having a plan for weed suppression can vastly improve garden crops. Pictured is kale planted in ...
In addition to the scientific presentation, SynCardia will exhibit at booth 409, where attendees can learn more about the SynCardia Total Artificial Heart and ongoing efforts to expand access to life ...
Sponsored by Organon Your story is still unfolding, with new chapters full of romance and adventure. You’re already busy with ...
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results